Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ASLN

Aslan Pharmaceuticals

$2.28

-0.105 (-4.41%)

07:28
12/10/19
12/10
07:28
12/10/19
07:28
Recommendations
Aslan Pharmaceuticals analyst commentary at H.C. Wainwright »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
ASLN

Aslan Pharmaceuticals

$5.40

1.56 (40.63%)

06:09
12/03/19
12/03
06:09
12/03/19
06:09
Syndicate
Aslan Pharmaceuticals 5.125M share Secondary priced at $2.50 »

H.C. Wainwright acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ASLN

Aslan Pharmaceuticals

$6.24

2.4 (62.50%)

12:52
12/02/19
12/02
12:52
12/02/19
12:52
Syndicate
Aslan announces offering of American Depositary Shares »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASLN

Aslan Pharmaceuticals

$3.84

1.61 (72.20%)

09:06
12/02/19
12/02
09:06
12/02/19
09:06
Upgrade
Piper upgrades Aslan to Overweight with $8 target after atopic dermatitis data »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASLN

Aslan Pharmaceuticals

$3.84

1.61 (72.20%)

09:01
12/02/19
12/02
09:01
12/02/19
09:01
Upgrade
Aslan Pharmaceuticals rating change at Piper Jaffray »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASLN

Aslan Pharmaceuticals

$3.84

1.61 (72.20%)

05:42
12/02/19
12/02
05:42
12/02/19
05:42
Hot Stocks
Aslan Pharmaceuticals reports preliminary data from ASLAN004 study »

ASLAN Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASLN

Aslan Pharmaceuticals

$0.95

0.528 (125.12%)

09:54
11/22/19
11/22
09:54
11/22/19
09:54
Hot Stocks
Aslan soars 186% after journal reports new acute myeloid leukemia data »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASLN

Aslan Pharmaceuticals

$0.38

-0.1145 (-23.02%)

07:23
11/14/19
11/14
07:23
11/14/19
07:23
Recommendations
Aslan Pharmaceuticals analyst commentary at H.C. Wainwright »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASLN

Aslan Pharmaceuticals

$0.89

-1.07 (-54.59%)

10:41
11/11/19
11/11
10:41
11/11/19
10:41
Downgrade
Aslan Pharmaceuticals rating change at Piper Jaffray »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASLN

Aslan Pharmaceuticals

$1.96

-0.02 (-1.01%)

09:24
11/11/19
11/11
09:24
11/11/19
09:24
Downgrade
Aslan Pharmaceuticals rating change at BTIG »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.